Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT05502146
Other study ID # 2022/05
Secondary ID
Status Completed
Phase Phase 4
First received
Last updated
Start date August 17, 2022
Est. completion date October 1, 2022

Study information

Verified date January 2023
Source Mersin University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

In this study the investigators will compare two doses of norepinephrine bolus (6 mcg and 8 mcg) in management of maternal hypotensive episode after spinal block during cesarean delivery.


Description:

Maternal hypotension after spinal anesthesia is a common and serious complication during cesarean delivery. Despite all preventive measures, the incidence of hypotension is still around 20%. In these cases, maternal hypotension treatment is usually required using vasopressor boluses. One of the vasopressors commonly used during cesarean delivery is norepinephrine, especially recently. Although phenylephrine has long been the first choice for the prevention and treatment of maternal hypotension, its use may cause bradycardia and decreased maternal cardiac output. Norepinephrine is an alpha adrenergic agonist with weak beta adrenergic agonistic activity; therefore, it does not cause significant cardiac depression like phenylephrine. Norepinephrine has been introduced for use during cesarean delivery with promising results. Several previous studies have investigated the efficacy of norepinephrine infusion in preventing maternal hypotension. A dose-response study investigated the best dose of Norepinephrine for the prevention of hypotension. In the dose-response study mentioned above, a dose of 6 mcg was reported as the best dose for prophylaxis against hypotension. There are very limited studies investigating the best bolus dose of norepinephrine for the treatment of maternal hypotensive episode, and the optimal dose recommendation is uncertain. In this study, researchers will investigate the efficacy and adverse effects of two bolus doses of norepinephrine (6 mcg and 8 mcg) in the management of a maternal hypotensive episode after subarachnoid block during cesarean delivery.


Recruitment information / eligibility

Status Completed
Enrollment 200
Est. completion date October 1, 2022
Est. primary completion date October 1, 2022
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Female
Age group 18 Years to 49 Years
Eligibility Inclusion Criteria: - Woman, - ASA I-II, - 18-49 age range, - Actual body weight >50 kg,<90 kg - Actual height >150cm, <180cm - Patients undergoing surgery under elective conditions and emergency cases for non-bleeding reasons - Fasting period is appropriate, - Term pregnancy (38-42 weeks), - Patients without cardiovascular disease - Spinal block that does not reach the high level (<T4), - Patients without diagnosis of stage 2 or higher hypertension hypertension (Stage 2 hypertension is defined as a systolic blood pressure of more than 160 mmHg and a diastolic blood pressure of more than 90 mmHg.), - Patients without vasoactive drug use, - Preop Systolic Blood Pressure >90 mmHg, - Bleeding less than 750 ml, - Patients who signed the informed consent form to be included in the study Exclusion Criteria: - ASA III-IV, - Pregnant women outside the age range of 18-49, - Actual body weight >90kg, <50kg - Actual height >180cm, <150cm - Patients with inappropriate fasting time - Preterm pregnancy (<38 weeks) or postterm pregnancy (>42 weeks) - Bleeding amount more than 750 ml - Emergency surgery with bleeding (previa, placental abruption, etc.)- Pregnant with cardiovascular system disease, - High block level (>T4) - Having a diagnosis of stage 2 or higher hypertension hypertension (Stage 2 hypertension is defined as a systolic blood pressure of more than 160 mmHg and a diastolic blood pressure of more than 90 mmHg.), - Use of vasoactive drugs, - Preop Systolic Blood Pressure <90 mmHg - Patients who did not sign the informed consent form to be included in the study

Study Design


Intervention

Drug:
Noradrenaline Bitartrate
An intravenous bolus of norepinephrine 6 mcg will be administered for management of maternal hypotension.
Bupivacaine Hydrochloride
Subarachnoid block will be performed using Bupivacaine hydrochloride (2.5 mL)
Noradrenaline Bitartrate
An intravenous bolus of norepinephrine 8 mcg will be administered for management of maternal hypotension.
Bupivacaine Hydrochloride
Subarachnoid block will be performed using Bupivacaine hydrochloride (2.5 mL)

Locations

Country Name City State
Turkey Mersin University Mersin Yenisehir

Sponsors (1)

Lead Sponsor Collaborator
Mersin University

Country where clinical trial is conducted

Turkey, 

References & Publications (4)

Carvalho B, Dyer RA. Norepinephrine for Spinal Hypotension during Cesarean Delivery: Another Paradigm Shift? Anesthesiology. 2015 Apr;122(4):728-30. doi: 10.1097/ALN.0000000000000602. No abstract available. — View Citation

Chen D, Qi X, Huang X, Xu Y, Qiu F, Yan Y, Li Y. Efficacy and Safety of Different Norepinephrine Regimens for Prevention of Spinal Hypotension in Cesarean Section: A Randomized Trial. Biomed Res Int. 2018 May 23;2018:2708175. doi: 10.1155/2018/2708175. eCollection 2018. — View Citation

Hassabelnaby YS, Hasanin AM, Adly N, Mostafa MMA, Refaat S, Fouad E, Elsonbaty M, Hussein HA, Mahmoud M, Abdelwahab YM, Elsakka A, Amin SM. Comparison of two Norepinephrine rescue bolus for Management of Post-spinal Hypotension during Cesarean Delivery: a — View Citation

Onwochei DN, Ngan Kee WD, Fung L, Downey K, Ye XY, Carvalho JCA. Norepinephrine Intermittent Intravenous Boluses to Prevent Hypotension During Spinal Anesthesia for Cesarean Delivery: A Sequential Allocation Dose-Finding Study. Anesth Analg. 2017 Jul;125(1):212-218. doi: 10.1213/ANE.0000000000001846. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Rate of successful management of maternal hypotension Number of patients with successful management of a maternal hypotensive episode (defined as systolic blood pressure greater than 80% of baseline measurement and systolic blood pressure greater than 90 mmHg) Successful management is considered to be successful management if blood pressure does not fall below 90 mmHg and 80% of baseline measurement within 6 minutes after norepinephrine administration after hypotension develops. After spinal anesthesia until the end of surgery
Primary Number of Noradrenaline doses administered and total dose amount Evaluation of the number of bolus noradrenaline doses and the total dose required for the treatment of maternal hypotension after spinal block. After spinal anesthesia until the end of surgery
Secondary Incidence of reactive hypertension Number of patients with reactive hypertension (defined as systolic blood pressure =120% from the baseline reading after administration of norepinephrine bolus). After spinal anesthesia until the end of surgery
Secondary Incidence of bradycardia Patients with a heart rate less than 40 bpm After spinal anesthesia until the end of surgery
Secondary Evaluation of "Appearance, Pulse, Grimace, Activity, and Respiration" (APGAR) score The minimum score that can be obtained from this scale is 0 and the maximum is 10 points.
Scoring will be calculated at 1 and 5 minutes immediately after birth. A score of 9 to 10 is consistent with a better clinical outcome, while a score of 8 or less will be considered a poor clinical outcome.
The first 5 minutes after birth
Secondary Umbilical cord blood gas analyses of fetus Potential of hydrogen (pH): Normal range is between 7.35-7.45 The first 5 minutes after birth
Secondary Umbilical cord blood gas analyses of fetus Partial arterial oxygen pressure (PaO2, mmHg): Normal range is between 50-100 mmHg The first 5 minutes after birth
Secondary Umbilical cord blood gas analyses of fetus Partial carbon dioxide pressure (PaCO2, mmHg): Normal range is between 35-45 mmHg The first 5 minutes after birth
Secondary Umbilical cord blood gas analyses of fetus Bicarbonate (HCO3, mEq/liter): Normal range is between 22-26 mEq/liter The first 5 minutes after birth
Secondary Umbilical cord blood gas analyses of fetus Base deficit (BE, mEq/liter): Normal range is between +2 to -2 mEq/liter The first 5 minutes after birth
Secondary The frequency of side effects after norepinephrine the number of patients with side effects (Nausea, vomiting, headache, tinnitus, arrhythmia, chest pain, etc.) During surgery after spinal block
Secondary The frequency of side effects after subarachnoid block Side effects seen after spinal block and in patients who have not yet received noradrenaline During surgery after spinal block
Secondary Effect of noradrenaline on heart rate variability Comparison of the rates of change in heart rate in measurements before and after two different bolus doses of noradrenaline. Measurements just before and 1 minute after noradrenaline administration
See also
  Status Clinical Trial Phase
Terminated NCT04377984 - Impact of a Strategy Combining Morphine Savings and Anesthesia Technique on the Quality of Post-operative Rehabilitation
Recruiting NCT03248817 - Phenylephrine Infusion in Cesarean Delivery Phase 4
Completed NCT05037383 - Motion and Viewing Analysis of Surgeons During Minimally Invasive Gynecological Interventions N/A
Completed NCT05933993 - Mothers Experience of Pain Following Elective Cesarean Section. A Qualitative Study.
Recruiting NCT05021315 - Vaginal Cleaning Using Povidone Iodine Before CS to Reduce Postoperative Wound Infection Phase 3
Terminated NCT03246919 - Ideal Time of Oxytocin Infusion During Cesarean Section Phase 4
Completed NCT06403215 - Effect of Chewing Gum and Drinking Fennel Tea N/A
Not yet recruiting NCT06446258 - Assessment of the Impact of Soft Tissue Mobilization on the Scar in Patients After Cesarean Section N/A
Recruiting NCT06247852 - Persistent Pain After Cesarean Delivery - A Danish Multicenter Cohort Study
Not yet recruiting NCT06017076 - Effect of Preoperative Oral Energy Drinks Compared to Warming Matress on Body Temperature During Combined Spinal-epidural Anesthesia for Elective Cesarean Delivery. N/A
Completed NCT05005871 - Comparison of Quadratus Lumborum Intramuscular and Transmuscular in Postoperative Pain N/A
Recruiting NCT04518176 - Bilateral Uterine Artery Ligation During the Cesarean Delivery of Twins N/A
Not yet recruiting NCT04505644 - Lidocaine Patch Versus Intravenous Lidocaine in Pain Relief After Cesarean Section N/A
Not yet recruiting NCT03985618 - The MODE Trial: Planned Caesarean Section Versus Induction of Labour for Women With Class III Obesity N/A
Completed NCT04046510 - Comparaison of 3 Protocols of Ocytocin Administration in C Section N/A
Completed NCT03302039 - Three Protocols for Phenylephrine Administration in Cesarean Delivery Phase 4
Completed NCT03318536 - Effect of Granisetron on Usage of Sympathomimetics During Caesarean Section
Recruiting NCT03682510 - B-Lynch Transverse Compression Suture Versus a Sandwich Technique (N&H Technique) for Complete Placenta Previa N/A
Recruiting NCT03651076 - Traxi Panniculus Retractor for Cesarean Delivery N/A
Not yet recruiting NCT06060327 - Comparing Tranexamic Acid Versus Ecbolics in Preventing Hemorrhage During and After Cesarean Section N/A